ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anemoside B4 protects against chronic relapsing colitis in mice by modulating inflammatory response, colonic transcriptome and the gut microbiota

Han, Qian; Deng, Li-rong; Zou, Min; Tang, Hua-zheng; Huang, Chang-yin; Chen, Fang-jun; Tomlinson, Brian; Li, Yan-hong*2
PHYTOMEDICINE2022-11DOI: 10.1016/j.phymed.2022.154416
6被引6阅读
引用收藏
分享

摘要

Background: Anemoside B4 (AB4) is reported to prevent acute colitis when given via intraperitoneal injection by two recent studies. However, whether oral AB4 protects against chronic colitis which resembles the clinical phenotype of ulcerative colitis (UC) and its mechanism of action are largely unknown. @@@ Purpose: To systemically investigate the effects of oral AB4 against chronic colitis and illustrate the underlying mechanism of action. @@@ Methods: The preventive, therapeutic, and dose-dependent effects of AB4 against UC were examined in mice with acute or chronic relapsing colitis induced by dextran sulfate sodium (DSS). The inflammatory responses, colonic transcriptome, and 16S rDNA sequencing of the intestinal content of mice were analyzed. @@@ Results: Oral administration of AB4 alleviated disease severity and colon shortening in mice with chronic relapsing colitis in a dose-dependent manner. The effects of AB4 were comparable to those of two positive-control compounds: tofacitinib and berberine. Unlike tofacitinib, AB4 did not have a deleterious effect on DSS-induced splenic swelling and anemia. Furthermore, AB4 inhibited the inflammatory responses of colitis, as evidenced by in-vivo, ex-vivo, and in-vitro studies. Transcriptomics revealed that AB4 treatment reversed the DSS-mediated decrease in the expression of colonic Pelo, B3gat2 and Mir8010. In addition, AB4 reversed DSS-induced alterations in the intestinal microbiome in mice. Through fecal microbiota transplantation, we proved that AB4 partially exerted its anti-colitis effects by modulating the gut microbiota. @@@ Conclusions: We demonstrated for the first time that AB4 has dose-dependent therapeutic effects against chronic relapsing colitis by modulating the inflammatory response, colonic gene expression, and intestinal microbiota.

学科与关键词

关键词
Anemoside B4Pulsatilla chinensis experimental EolitisInflammatory responseTranscriptomicsGut microbiota
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-11
卷期
第 106 卷
页码
154416
DOI
10.1016/j.phymed.2022.154416
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82174048]; Natural Science Foundation of Guangdong Province [2022A1515012630]; Guangzhou Basic Research Foundation [202201010037]; China Scholar-ship Council [CSC201806155103]

作者

  • H

    Han, Qian (第一作者)

    2

  • D

    Deng, Li-rong

    2

查看全部 8 位作者收起作者
  • Z

    Zou, Min

    2

  • T

    Tang, Hua-zheng

    2

  • H

    Huang, Chang-yin

  • C

    Chen, Fang-jun

    2

  • T

    Tomlinson, Brian

  • L

    Li, Yan-hong (通讯)

    2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417